Moorman AC - Search Results

1

Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient Study.

Young B, Buchacz K, Baker RK, Moorman AC, Wood KC, Chmiel J, Brooks JT; HIV Outpatient Study Investigators. Young B, et al. Among authors: moorman ac. J Int Assoc Physicians AIDS Care (Chic). 2007 Sep;6(3):178-87. doi: 10.1177/1545109707300676. Epub 2007 Jun 19. J Int Assoc Physicians AIDS Care (Chic). 2007. PMID: 17579126

2

Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study.

Young B, Buchacz K, Moorman A, Wood KC, Brooks JT; HIV Outpatient Study (HOPS) Investigators. Young B, et al. AIDS Patient Care STDS. 2009 Aug;23(8):589-92. doi: 10.1089/apc.2008.0232. AIDS Patient Care STDS. 2009. PMID: 19591609

3

Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected persons.

Young B, Weidle PJ, Baker RK, Armon C, Wood KC, Moorman AC, Holmberg SD; HIV Outpatient Study (HOPS) Investigators. Young B, et al. Among authors: moorman ac. AIDS Patient Care STDS. 2006 Apr;20(4):238-44. doi: 10.1089/apc.2006.20.238. AIDS Patient Care STDS. 2006. PMID: 16623622

4

Renal function in patients receiving tenofovir with ritonavir/lopinavir or ritonavir/atazanavir in the HIV Outpatient Study (HOPS) cohort.

Buchacz K, Young B, Baker RK, Moorman A, Chmiel JS, Wood KC, Brooks JT. Buchacz K, et al. J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):626-8. doi: 10.1097/01.qai.0000242461.35768.45. J Acquir Immune Defic Syndr. 2006. PMID: 17133215 Clinical Trial. No abstract available.

5

Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients.

Palella FJ Jr, Chmiel JS, Moorman AC, Holmberg SD; HIV Outpatient Study Investigators. Palella FJ Jr, et al. Among authors: moorman ac. AIDS. 2002 Aug 16;16(12):1617-26. doi: 10.1097/00002030-200208160-00007. AIDS. 2002. PMID: 12172083

6

Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort.

Lichtenstein KA, Armon C, Baron A, Moorman AC, Wood KC, Holmberg SD; HIV Outpatient Study Investigators. Lichtenstein KA, et al. Among authors: moorman ac. Clin Infect Dis. 2005 Jan 1;40(1):148-57. doi: 10.1086/426076. Epub 2004 Dec 6. Clin Infect Dis. 2005. PMID: 15614705

7

Deloria-Knoll M, Chmiel JS, Moorman AC, Wood KC, Holmberg SD, Palella FJ; HIV Outpatient Study (HOPS) Investigators. Deloria-Knoll M, et al. Among authors: moorman ac. AIDS Patient Care STDS. 2004 Dec;18(12):721-7. doi: 10.1089/apc.2004.18.721. AIDS Patient Care STDS. 2004. PMID: 15659883

8

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD; HIV Outpatient Study Investigators. Palella FJ Jr, et al. Among authors: moorman ac. J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34. doi: 10.1097/01.qai.0000233310.90484.16. J Acquir Immune Defic Syndr. 2006. PMID: 16878047

9

Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients.

Tedaldi EM, Brooks JT, Weidle PJ, Richardson JT, Baker RK, Buchacz K, Moorman AC, Wood KC, Holmberg SD; HOPS Investigators. Tedaldi EM, et al. Among authors: moorman ac. J Acquir Immune Defic Syndr. 2006 Sep;43(1):35-41. doi: 10.1097/01.qai.0000234084.11291.d4. J Acquir Immune Defic Syndr. 2006. PMID: 16885779

10

Initiation of antiretroviral therapy at CD4 cell counts >/=350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiency.

Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Moorman AC, Wood KC, Holmberg SD, Brooks JT; HIV Outpatient Study (HOPS) Investigators. Lichtenstein KA, et al. Among authors: moorman ac. J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):27-35. doi: 10.1097/QAI.0b013e31815acacc. J Acquir Immune Defic Syndr. 2008. PMID: 17971714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters